Home

September 2022

7 key CVIS trends | 2 medications recalled due to labeling mix-up | AKI & TAVR (09/30/2022)

Previewing AHA 2022 | 2 popular meds recalled due to mix-up | Coffee & CVD | More big stories from the last week (09/30/2022)

News Alert: FDA announces recall of 2 cardiovascular medications due to labeling mix-up (09/30/2022)

Treating TAVR-related strokes | CCTA in the ED | Cardiologist arrested for child pornography (09/29/2022)

Drinking coffee linked to a lower risk of heart disease, death | Congenital heart imaging with CT | New Impella data (09/28/2022)

Gaps in access to AFib care | FFR-angio better than fluoro guided PCI | Cardiac CT for cardio-oncology (09/27/2022)

Structural Heart Disease Highlights: A malfunction risk with MitraClip devices | CT imaging for TAVR & TMVR (09/27/2022)

American Heart Association 2022 late-breaking studies announced | New data on Intrepid TMVR system (09/26/2022)

FDA clears AI model & approves new TAVR valve | Cardiologists turn up heat on Congress to stop Medicare cuts (09/23/2022)

FDA commissioner's fiery speech | AI outperforms docs | CCTA vs. ICA | More big stories from the last week! (09/23/2022)

Heart Rhythm Highlights: Women may face a higher AFib risk than men | Diagnosing & treating CIED infections (09/23/2022)

CCTA vs. ICA for stable chest pain | Historic new study investigates IVL among female patients (09/22/2022)

Heart Health Highlights: Artificial sweeteners linked to heart problems | Is CBD safe for CVD patients? (09/22/2022)

Pulmonary artery denervation shows promise for PAH | VIDEO: Addressing the tricuspid valve with new interventions (09/21/2022)

FDA clears a long-term cardiac monitor for pediatric patients for first time | More big news out of TCT 2022 (09/20/2022)

TAVR Highlights: Evolving views on AVR | New data presented at TCT 2022 & ESC Congress 2022 | Much more! (09/20/2022)

FDA commissioner shares 3 big concerns at TCT | TAVR embolic protection devices fail to reduce stroke risk (09/19/2022)

AI can assess PET/CT for calcium scoring | VIDEO: CT imaging to plan TAVR and TMVR interventions | Pascal gains FDA (09/16/2022)

Flurpiridaz promises to expand cardiac PET | Tricuspid therapies moving ahead of mitral | More news this week (09/16/2022)

FDA clears Edwards Pascal for mitral valve repair | Trial data vs. MitraClip is a TCT late-breaker (09/16/2022)

Cardiologist compensation hits $622K, up 32% from 10 years ago | Birth control-related blood clots (09/15/2022)

Cardiac Imaging Highlights: Promising new flurpiridaz data | CCTA helpful for planning coronary procedures (09/15/2022)

Interventional Cardiology Highlights: Cardiologists make history | Previewing TCT 2022 | Much more! (09/15/2022)

Surgeons perform the world’s first partial heart transplant | CVD in women: What imagers need to know (09/14/2022)

Is CBD safe for patients with heart disease? | HFpEF patients with MR may face a higher mortality risk (09/13/2022)

Vascular & Endovascular Highlights: The FDA's busy month | DAPT after CABG | Much more! (09/13/2022)

Positive flurpiridaz data will likely increase cardiac PET | Tricuspid therapies moving ahead of mitral seeking FDA approval (09/12/2022)

VIDEO: Trends in Structural Heart Procedural Imaging | new EP ablation system enters U.S. trial (09/12/2022)

TAVR patients with CAD | FDA's MitraClip warning | SAVR after TAVR | More news from the last week (09/08/2022)

Artificial sweeteners & CVD | A new malfunction risk with Abbott’s MitraClip devices | DOACs after TAVR (09/08/2022)

News Alert: FDA warns of a new malfunction risk with Abbott’s MitraClip devices (09/08/2022)

Heart Failure Highlights: Updated data on COVID-related myocarditis | Medtronic's new recall | NSAIDs & T2D (09/08/2022)

SAVR after TAVR linked to a high mortality risk | Boston Scientific's new FDA approval (09/07/2022)

Previewing TCT 2022 with Juan Granada | TEER safe for treating atrial secondary mitral regurgitation (09/06/2022)

Economics Highlights: Cardiologists earn healthcare's highest salaries | Medtronic's big acquisition | AI's impact (09/06/2022)

TAVR patients with CAD face a greater risk of death | Monkeypox linked to acute myocarditis (09/02/2022)

A historic procedure | 6 key sessions from ESC Congress 2022 | More big stories from the last week! (09/02/2022)

Care Delivery Highlights: New-look TMVR system impresses | A fresh look at edoxaban among elderly patients (09/02/2022)

New guidelines for CIED infections | AI boosts care for female heart attack patients | JenaValve raises $100M (09/01/2022)

August's 10 most popular stories: A historic procedure, a massive recall, high salaries & more (09/01/2022)

Design by Adaptive Theme